Bhanwra, S., and K. Ahluwalia. “Empagliflozin: The Latest SGLT2 Inhibitor on the Block”. International Journal of Basic & Clinical Pharmacology, vol. 5, no. 2, Dec. 2016, pp. 539-42, doi:10.18203/2319-2003.ijbcp20160777.